| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Abbvie |
| Recipient: You |
| Company: Impact Biomedicines |
| Recipient: You |
| Company: Celgene |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: BMS |
| Recipient: You |
| Company: Taiho |
| Recipient: You |
| Company: CTI Biopharma |
| Recipient: You |
| Company: Threadwell therapeutics |
| Recipient: You |
| Company: Blueprint Medicines |
| Recipient: You |
| Company: SERVIER |
| Recipient: You |
| Company: Kymera |
| Recipient: You |
| Company: Bristol-Myers Squibb/Celgene |
| Recipient: Your Institution |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Celgene |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: Astex Pharmaceuticals |
| Recipient: Your Institution |
| Company: NS Pharma |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
| Company: Janssen Oncology |
| Recipient: Your Institution |
| Company: Oncothyrapy |
| Recipient: Your Institution |
| Company: Agios |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: CTI BioPharma Corp |
| Recipient: Your Institution |
| Company: Kartos |
| Recipient: Your Institution |
| Company: Aprea AB |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: Daiichi Sankyo |
| Recipient: Your Institution |
| Company: Loxo |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|